Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Extension of JOINTSTEM in Knee Osteoarthritis
NCT04825730Not yet recruiting
- Sponsor
- R Bio
- Start
- Dec 2023
- Primary completion
- Dec 2028
- Modality
- Stem Cell Therapies
01
Overview
Open-label, single-arm trial of JOINTSTEM in knee osteoarthritis (OA), sponsored by R Bio. Primary endpoint: Adverse Events at 60 months. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
JOINTSTEM
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04825730.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04825730.